Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP.

Am J Epidemiol. 2001 Apr 1;153(7):619-27.

PMID:
11282787
2.

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.

Markowitz LE, Sirisopana N, Charonwatanachokchai A, Julvanichpong W, Siraprapasiri T, Palanuvej T, Siriwongrangsun P, Tungsakul V, Pumratana K, Chitwarakorn A, Michael RA, Brown AE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):488-94.

PMID:
10225232
4.

The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials.

Djomand G, Metch B, Zorrilla CD, Donastorg Y, Casapia M, Villafana T, Pape J, Figueroa P, Hansen M, Buchbinder S, Beyrer C; 903 Protocol Team..

J Acquir Immune Defic Syndr. 2008 May 1;48(1):82-9. doi: 10.1097/QAI.0b013e31817236ab.

PMID:
18391750
5.

Will preventive HIV vaccine efficacy trials be possible with female injection drug users?

Meyers K, Metzger DS, McLellan AT, Navaline H, Sheon AR, Woody GE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):577-85.

PMID:
8548338
6.

Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate.

Buchbinder SP, Douglas JM Jr, McKirnan DJ, Judson FN, Katz MH, MacQueen KM.

J Infect Dis. 1996 Nov;174(5):954-61.

PMID:
8896495
7.

Human immunodeficiency virus (HIV) infection in parenteral drug users: evolution of the epidemic over 10 years. Valencian Epidemiology and Prevention of HIV Disease Study Group.

Hernández-Aguado I, Aviño MJ, Pérez-Hoyos S, González-Aracil J, Ruiz-Pérez I, Torrella A, García de la Hera M, Belda F, Fernández E, Santos C, Trullen J, Fenosa A.

Int J Epidemiol. 1999 Apr;28(2):335-40.

PMID:
10342700
9.

Human immunodeficiency virus incidence and risk behavior in the 'Projeto Rio': results of the first 5 years of the Rio de Janeiro open cohort of homosexual and bisexual men, 1994-98.

Sutmöller F, Penna TL, de Souza CT, Lambert J; Oswaldo Cruz Foundation STD/HIV Prevention Group..

Int J Infect Dis. 2002 Dec;6(4):259-65.

PMID:
12718818
10.

Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.

Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE.

Arch Intern Med. 2001 May 28;161(10):1281-8.

PMID:
11371255
11.

Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.

Nelson KE, Vlahov D, Solomon L, Cohn S, Muñoz A.

Arch Intern Med. 1995 Jun 26;155(12):1305-11.

PMID:
7778962
12.

Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.

Jackson DJ, Martin HL Jr, Bwayo JJ, Nyange PM, Rakwar JP, Kashonga F, Mandaliya K, Ndinya-Achola JO, Kreiss JK.

AIDS. 1995 Nov;9(11):1279-83.

PMID:
8561982
13.

Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men.

Bartholow BN, MacQueen KM, Douglas JM Jr, Buchbinder S, McKirnan D, Judson FN.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Oct 1;16(2):108-15.

PMID:
9358105
14.

High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study.

Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, Buchbinder S, Koblin B, Celum C.

Am J Epidemiol. 2006 Oct 15;164(8):733-41. Epub 2006 Aug 8.

PMID:
16896053
15.

Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.

Nelson KE, Vlahov D, Galai N, Astemborski J, Solomon L.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S201-5.

PMID:
7865301
16.

Incidence of HIV infection in stable sexual partnerships: a retrospective cohort study of 1802 couples in Mwanza Region, Tanzania.

Hugonnet S, Mosha F, Todd J, Mugeye K, Klokke A, Ndeki L, Ross D, Grosskurth H, Hayes R.

J Acquir Immune Defic Syndr. 2002 May 1;30(1):73-80.

PMID:
12048366
17.

Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials.

Scheer S, Douglas JM Jr, Vittinghoff E, Bartholow BN, McKirnan D, Judson FN, MacQueen KM, Buchbinder S.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):172-8.

PMID:
10048905
18.

Incident HIV infection in a high-risk, homosexual, male cohort in Rio de Janeiro, Brazil.

Harrison LH, do Lago RF, Friedman RK, Rodrigues J, Santos EM, de Melo MF, Moulton LH, Schechter M.

J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):408-12.

PMID:
10458622
19.

Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.

Suntharasamai P, Martin M, Vanichseni S, van Griensven F, Mock PA, Pitisuttithum P, Tappero JW, Sangkum U, Kitayaporn D, Gurwith M, Choopanya K; Bangkok Vaccine Evaluation Group..

Addiction. 2009 Feb;104(2):235-42. doi: 10.1111/j.1360-0443.2008.02436.x.

PMID:
19149819
20.

Feasibility of northern Thai factory workers as participants in HIV vaccine trials.

Natpratan C, Nantakwang D, Beyrer C, Kunawararak P, Gunhom C, Celentano DD, Nelson KE, Khamboonruang C.

Southeast Asian J Trop Med Public Health. 1996 Sep;27(3):457-62.

PMID:
9185253

Supplemental Content

Support Center